Total Funding
85
71
Total FundingVenture - Series Unknown raised
Growth Score
-3 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
40214
SynDevRx develops polymer-based drug conjugates for small molecule drug activity.
Bradley J Carver: Co-founder, President, CEO and Chairman- James M. Shanahan: Co-Founder and Chief Business Officer
About the Company
Syndevrx is a biotech company that specializes in the development of treatments for cancers sensitive to metabolic hormones. Its drugs focus to treat the tumor directly and improve the underlying metabolic hormone dysfunction.
